Five late-stage drug candidates are drawing attention as researchers search for more effective, targeted, and convenient options for people living with ulcerative colitis.
New York, 8 September 2026 – The treatment landscape for ulcerative colitis is entering a new phase,...
AI, investment, biotechnology and stronger regional partnerships are creating a new path for Asia Pacific healthcare companies to take their ideas from the laboratory to international markets
Singapore, 1 September 2026 – Asia Pacific’s healthcare industry is entering a new...
A new study shows how quantum computing could help AI create more useful drug candidates and explore possibilities beyond its training data
Burnaby, British Columbia, 25 August 2026 – Generative artificial intelligence is quickly becoming an important tool in drug...
Philips report shows artificial intelligence is helping US healthcare professionals save time, manage workloads and improve clinical efficiency
Cambridge, Massachusetts, 18 August 2026 – Artificial intelligence is moving beyond pilot projects and becoming a more practical part of everyday healthcare...
Biomarker discovery lies at the heart of the translational gap in drug development. Too often, programs stall, and compounds fail in late-stage trials. Retrospective analyses repeatedly point to the same issue, a lack of mechanistic insight into the underlying...
Developing a new medicine is difficult. Scientists must understand a disease, identify a biological target, find a compound or biologic that modulates it, and show that it is safe and effective. Most experimental drugs fail before reaching patients.
AI systems...
Approximately $10B is being invested globally in the development and application of AI in Drug Discovery in 2026. As a systems modeler, I see current investment focusing on dealing with the complicated aspects of drug discovery but not necessarily...
Most search queries today see no click through - artificial intelligence gives responses on the spot. Six out of ten times,users take what they need right there. Companies in life sciences notice this shift, adapting fast.
Instead of only chasing...
